Parkinson  
 

NeuroResearch Clinics, Inc.

 
  AMA Category 1  
  Continuing Medical Education  
   
   
   
   
 
HOME PAGE
 
The Diseases
 
Attention Deficit ADD ADHD
Anxiety / Panic Attacks
Alzheimer's Dementia
Depression
Suicide
Fibromyalgia
Insomnia
Migraine headaches
Parkinson
Trichotillomania
Obsessive Compulsive Disorder-OCD
 
Antidepressants
Brain Damage
Neurotransmitter Depletion
Protocols
Side Effects
neurotransmitter testing
 
University Writings About NeuroResearch Clinics
 
Neurotoxins
Technical Guide
Narrated Slide Shows
Public Interviews
Med Ed Web Site
DBS Labs Web Site
Faba Bean Warning
Webinars
Sitemap
Contact Us
 
 

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

NR-Parkinson-research

 
 
Billabong World Championship of Surfing Bonsai Pipeline Oahu Hawaii
Photo by Marty L. Hinz, MD
 
Parkinson
Contact us or find a caregiver using this approach.
 

Parkinson

Proper Management of Amino Acids

 

Written by: Marty L. Hinz, MD
President Clinical Research
NeuroResearch Clinics, Inc.
Cape Coral, Florida USA Research Office
 

 Parkinson

Proper Management of Amino Acids: TREATMENT PROTOCOL

  If a patient is taking Carbidopa / Levodopa (Sinemet®) or other drugs, such as dopamine agonists, continue the drugs and start amino acid treatment. At the first sign of improvements, stop the Carbidopa compound. Carbidopa will interfere with fine-tuning the results as the patient improves.

Parkinson PROTOCOL: WEEK 1

  • Start level 1 of the NeuroResearch Clinics "Tyrosine, 5-HTP, Levodopa and Cysteine protocol" with cofactors AM and at 4 PM.

WEEK 2

  • Continue week 1 dosing and start an additional 120 mg of Levodopa three times a day.

WEEK 3

  Obtain serotonin and dopamine urinary neurotransmitter testing then make dosing changes based on the laboratory reports. The goal of treatment is a urine dopamine level in the range of 6,000 to 8,000 micrograms of dopamine per gram of creatinine or relief of symptoms which ever comes first. Although, one patient required urinary dopamine levels of 14,000 in order to achieve relief of symptoms. The goal of the urinary serotonin is to establish it in the phase 3 therapeutic range.

  It generally takes 2 to 4 months to stabilize symptoms in the patient with Parkinson. Although rare patients have been observed that achieve complete remission of symptoms in one week. In general, patients who have been diagnosed and treated for Parkinson for 5 to 7 years or less get very good results. Patients in whom Parkinson has been treated over 7 years can be stabilized but the amount of time to do this increases significantly.

Parkinson

Parkinson
- Home Page

- Overview

- Parkinson Etiology in depth

- Levodopa depletes serotonin

- Sulfur amino acids

- Carbidopa

- Levodopa side effects

- The Parkinson on-off effect

- Proper treatment overview

- Proper management of amino acids

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parkinson-treatment
 

Parkinson

 
 
 

NO PARKINSON SECRET Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine with neurotransmitter testing as indicted to treat Parkinson in order to get the results documented by our doctors. Proper use these simple ingredients in Parkinson treatment is not simple. From time to time a patient will say, "Why do I want to take that, I can go to a health food store and buy it for my Parkinson?" People off the street buying in a health food store is like going to an art store and buying a bunch of oil paints then going home and expecting to paint like a master artist even though there is no previous painting experience. Overall this is some of the most sophisticated Parkinson treatment in medicine. These nutrients have tremendous Parkinson treatment potential due to their chemical properties. This potential is only fully realized in the hands of the trained professional.

 
 
Parkinson Tasmar
Parkinson NEJM
Parkinson NIH
 
Parkinson
 
If you need a medical speaker for AMA Category I CME call NeuroResearch Clinics, Inc.
NeuroResearch Clinics, Inc. only deals with and provides information to licensed health care professionals.
 
Parkinson
 
keyz keyb
 
Parkinson